PAUL KLOTMAN to Sodium Chloride Symporter Inhibitors
This is a "connection" page, showing publications PAUL KLOTMAN has written about Sodium Chloride Symporter Inhibitors.
Connection Strength
0.019
-
Double-blind, placebo-controlled trial of twice-daily nifedipine as a step-2 agent in mild essential hypertension. J Clin Hypertens. 1987 Dec; 3(4):579-88.
Score: 0.019
Connection Strength
The connection strength for concepts is the sum of the scores for each matching publication.
Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.